Chemotherapy better tolerated when matched to body's rhythm
BMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7109.623j (Published 13 September 1997) Cite this as: BMJ 1997;315:623- Zosia Kmietowicz
- London
Giving chemotherapy as a variable infusion that mimics circadian rhythms rather than as a constant infusion reduces fivefold the adverse events in patients with colorectal cancer, according to the results of a randomised trial. The technique of variable drug infusion, known as chronotherapy, may benefit all patients with cancer requiring drug therapy by improving response and tolerance, believe French researchers.
In their trial the investigators assigned 186 patients with previously untreated metastases from colorectal …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.